Summit Therapeutics Inc. $(SMMT)$ will participate in the 46th Annual Goldman Sachs Global Healthcare Conference on June 9, 2025, in Miami, Florida. The company will present a corporate overview and update on the progress, including the development of their innovative investigational bispecific antibody, ivonescimab. The presentation will be available live on Summit's website.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Summit Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250605847246) on June 05, 2025, and is solely responsible for the information contained therein.